Previous some studies suggested the addition of chemotherapy to radiation therapy after
surgery may have survival benefit in patients with high risk endometrial cancer. In addition,
docetaxel plus cisplatin regimen may have similar efficacy with paclitaxel plus carboplatin
which is currently used in most cases. However, docetaxel plus cisplatin may cause less
toxicity compared to paclitaxel plus carboplatin. Therefore, the investigators aimed to
analyze the efficacy of docetaxel plus cisplatin regimen followed by radiation therapy after
surgery in patients with high risk endometrial cancer.